Search for:
For Eun-Jung Park, a Long Road to “Highly Cited Researcher”

The 2018 roster of Highly Cited Researchers from the Web of Science Group includes more than 3,300 scientists. Although each name represents a chronicle of dedication, hard work, and the tenacious pursuit of a dream, some of the stories speak of exceptional and single-minded devotion to attaining a goal.   For South Korean researcher Eun-Jung […]

Mainland China’s anticipated biosimilar boom – potential and key drivers of the market

The market of major biologics in Mainland China has tripled since 2017, with the potential to grow five-fold over the next ten years – which could drive biosimilars growth. Clarivate expert Akash Saini discusses this market’s potential and key drivers.    The approval of Shanghai Henlius Biotech’s HLX01—a biosimilar of rituximab (Roche’s MabThera)—in February 2019 […]

Hot Topics at ASCO 2017 – Part 2

ASCO 2017 is nearly upon us, so here is the second of our blogs covering key data that will be released, this time in the latter part of the...

Alzheimer’s disease – the disease without cure or prevention

This article is a Clarivate Analytics Market Insight report, an ongoing series featuring expert reviews of hot topics in the pharma/biotech field, with analysis and discussion on the factors currently affecting the industry. Data leveraged for this analysis was gathered from Clarivate Analytics Cortellis.   The unmet need The new year has seen major setbacks […]

That was then but this is now… #OAWeek – Part 2

Yesterday I wrote about our history of providing an independent, neutral source for the world’s most influential journals, books, proceedings and data repositories, spanning more than 50 years. Like Eugene Garfield, we value what scientists and scholars do and we honor their commitment and dedication to their institutions and their colleagues. A vital research activity […]

Lung cancer – continued progress in personalized care

This article is a Clarivate Analytics Market Insight report, an ongoing series featuring expert reviews of hot topics in the pharma/biotech field, with analysis and discussion on the factors currently affecting the industry.

Accelerating – and maintaining – drug approvals in the U.S.

Bringing a drug to market is the ultimate milestone for any pharmaceutical firm that has invested significant effort, not to mention time and resources, into developing its product. But all that work and outlay does not stop at marketing approval—this achievement must be maintained. There can be various regulatory requirements that a firm must meet […]